Newsroom

Extra! Extra!
Read all about it!

Welcome to our Newsroom, your go-to source for the latest updates on Galapagos. Explore press releases, insightful blogs, and access our resource hub, complete with company materials, designed to provide media and journalists with comprehensive information about our company’s innovations and milestones

Press releasesDownload Center

The latest

​​Galapagos reports first quarter 2024 financial results​

Galapagos NV today announced its first quarter 2024 financial results and provided a business update and outlook for the remainder of 2024.

Read more

The latest

Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024

Galapagos today announces that all resolutions proposed at the company’s Annual and Extraordinary Shareholders’ Meetings (AGM and EGM) held on 30 April 2024 were approved.

Read more

The latest

Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024

Galapagos today announced that four abstracts, including two oral presentations on encore preliminary clinical and translational data for its seven-day vein-to-vein CAR-T product candidates GLPG5101 and GLPG5201, will be presented at the 50th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) to be held in Glasgow, UK, on 14-17 April 2024

Read more

STORIES

Reflecting on EBMT24 with Judith: A Recap from Glasgow

Judith looks back on our presence at the EBMT 2024 congress, which took place in Glasgow, Scotland. Star Trek, a typical Glaswegian pub and decentralized manufacturing, it’s all in a day’s work. Galapagos was present with a booth, 4 abstracts and 2 oral presentations on our 2 CD19* programs. Read more in Judith’s story.
ReadAll stories

Press releases

View All Press Releases

Follow our journey

Subscribe to receive our press releases

Do you want to stay up to date on our journey, as we are pioneering for patients?

Subscribe to our press releasesContact Media Relations